Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medibank Private ( (AU:MPL) ) has provided an update.
Medibank Private Limited has announced its long-term ambitions to accelerate growth as a health company, aiming to significantly increase earnings in its health segment and expand its policyholder market share by FY30. The company is focusing on four key health segments—wellbeing, primary care, community and acute care, and health insurance—to deliver greater value and drive long-term growth. CEO David Koczkar highlighted the need for a shift in the healthcare system towards prevention, community-based care, and digital health solutions, emphasizing Medibank’s role in this transition and its commitment to investing in technology and partnerships to meet evolving community needs.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.25 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a prominent player in the Australian healthcare industry, primarily offering health insurance products and services. The company focuses on enhancing customer and shareholder value by driving meaningful change across Australia’s health system, with a strong emphasis on customer health and wellbeing.
Average Trading Volume: 5,405,563
Technical Sentiment Signal: Buy
Current Market Cap: A$13.14B
See more data about MPL stock on TipRanks’ Stock Analysis page.